An orthogonal optogenetic gene regulation platform for dynamic, bidirectional, and multiplexed control in yeast

Background

Optogenetic control of gene expression in microorganisms like Saccharomyces cerevisiae (baker’s yeast) is a rapidly advancing field at the intersection of synthetic biology, metabolic engineering, and biotechnology. The ability to precisely regulate gene activity using light allows researchers to dynamically modulate cellular processes, optimize metabolic pathways, and improve the production of valuable chemicals, pharmaceuticals, and biofuels. This approach offers significant advantages over traditional chemical inducers, such as rapid reversibility, fine spatial and temporal resolution, and the potential for multiplexed control. As industrial and research applications increasingly demand more sophisticated and responsive genetic circuits, there is a growing need for systems that can independently and simultaneously regulate multiple genes with minimal interference, enabling complex metabolic engineering strategies and high-yield bioproduction.

However, current optogenetic and chemical-inducible systems in yeast face several limitations that hinder their broader utility. Many rely on endogenous regulatory pathways, such as the GAL regulon, which are prone to crosstalk and cannot easily provide independent control over multiple gene sets. Furthermore, most existing systems are unidirectional, only allowing gene activation or repression in response to a single stimulus, which restricts the flexibility needed for dynamic metabolic switching or bidirectional control. Chemical inducers often suffer from issues such as high cost, toxicity, or metabolic burden, and light-based systems can be limited by leakiness, slow response times, or insufficient tunability. These challenges make it difficult to achieve robust, orthogonal, and tunable gene expression necessary for advanced synthetic biology applications, particularly when precise, multi-layered control is required within a single organism.

Technology

This technology enables dynamic, bidirectional optogenetic control of gene expression in Saccharomyces cerevisiae (yeast) by integrating the Neurospora crassa Q System. The platform consists of three main components: the QF2 transcriptional activator, the QS repressor, and quinic acid as an inducer. QF2 activates gene expression from a synthetic P5xQUASf promoter, while QS inhibits QF2 activity—a repression that can be relieved by quinic acid. Two primary optogenetic circuit types are engineered: OptoQ-INVRT circuits, where blue light induces QS to repress QF2 (activating genes in darkness), and OptoQ-AMP circuits, where blue light directly induces QF2 (activating genes in light). These circuits are highly tunable for sensitivity, leakiness, and activation kinetics through genetic modifications, such as degron tags and promoter engineering. Importantly, the Q System operates orthogonally to the yeast GAL regulon, allowing for simultaneous, independent control of multiple genes within the same strain, which is particularly valuable for complex metabolic engineering tasks.

What differentiates this technology is its robust orthogonality and versatility, addressing key limitations of existing gene control systems in yeast. Unlike traditional systems, which often suffer from crosstalk or lack true bidirectional control, the Q System functions independently from the native GAL regulon, enabling the concurrent use of both Q-based and GAL-based circuits without interference. This allows precise, multiplexed regulation of gene expression, as demonstrated in applications such as dynamic switching between growth and production phases for acetoin biosynthesis, and fine-tuning the ratio of valuable metabolites like geraniol and linalool. The system’s rapid response, strong induction, low background activity, and compatibility with both chemical and light-based triggers make it highly adaptable for industrial biotechnology. Its modularity, tunability, and ability to function efficiently at low inducer concentrations further enhance its utility for automated, scalable, and dynamic metabolic engineering in yeast.

Benefits

• Enables bidirectional, tunable optogenetic control of gene expression in yeast using blue light and chemical induction.
• Orthogonal operation to the native GAL regulon allows simultaneous, independent regulation of multiple gene sets within the same strain.
• Rapid and strong gene activation or repression with customizable sensitivity, leakiness, and kinetics through engineered circuit variants.
• Facilitates dynamic metabolic engineering by enabling precise temporal control of growth and production pathways.
• Cost-effective and non-native chemical inducer (quinic acid) enhances system tunability and reduces crosstalk.
• Demonstrated utility in optimizing production of valuable metabolites like acetoin, geraniol, and linalool with fine control over product ratios.
• Extensible platform compatible with multichromatic optogenetic systems for complex, multiplexed gene regulation.
• Supports automated and scalable industrial biotechnology applications through programmable light inputs and genetic circuit design.

Applications

• Dynamic metabolic pathway optimization
• Programmable yeast-based biomanufacturing
• Precision fermentation for flavor compounds
• Automated multi-gene circuit control

Additional info

This platform integrates the *Neurospora crassa* Q System into *Saccharomyces cerevisiae* for bidirectional optogenetic and chemical control of gene expression. Utilizing QF2, QS, and quinic acid, it operates orthogonally to native yeast regulons. This enables dynamic, independent regulation of multiple genes, facilitating advanced metabolic engineering applications.